Fig. 1From: Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapseFlow chart of the study population. BRCA, breast cancer susceptibility gene; PARP, poly (ADP-ribose) polymerase (PARP) inhibitorsBack to article page